Geographic atrophy (GA) secondary to age-related macular degeneration (AMD) in participants already treated with GT005 in the previous studies GT005-01 (FOCUS), GT005-02 (EXPLORE) and GT005-03 (HORIZON).

• Study to evaluate the long-term safety of GT005 in participants having macular degeneration that led to geographic atrophy in their eyes and … Recruitment ended
  2024-510946-15-00 9 2022-12-08

Showing 1–1 of 1 trials